The contractor shall provide expertise in the development and optimization of antiretroviral therapy for children living with HIV.
Ended Awarded Last action
- Contract number
- 75N93020F00003
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $676,029
Award facts
- Opportunity
-
- 75N93020F00138 Solicitation number
- Contract value 76% obligated
-
- $676,029.00 Current, with exercised options
- $893,336.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $44,475 | |
| Funding Only Action | $213,746 | |
| Exercise an Option | $0 | |
| Exercise an Option | $210,503 | |
| Original award | $207,305 |
About this award
Advanced Bioscience Laboratories, Inc., doing business as Advanced Bioscience Laboratories Inc., has been awarded an $893,336 cost-plus-fixed-fee delivery order against the HIV Microbicides and Biomedical Prevention 2016-2021 master indefinite-delivery/indefinite-quantity contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this award, the contractor will provide expertise in the development and optimization of antiretroviral therapy for children living with HIV, supporting the agency's Comprehensive Resources for HIV Microbicides and Biomedical Prevention program. Work will be performed in Potomac, Maryland over a three-year period ending August 2023. No set aside designation or major subcontractors were identified.
Quick answers
Who was awarded contract 75N93020F00003?
75N93020F00003 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2020.
How much is contract 75N93020F00003 worth?
The government has obligated $676,029 on 75N93020F00003. Its potential value, with all options, is $893,336.
Is contract 75N93020F00003 an order under another contract?
Yes. 75N93020F00003 is a delivery order under HHSN272201600008I, an indefinite delivery contract, on HIV Microbicides and Biomedical Prevention 2016-2021.
Was contract 75N93020F00003 competed?
The extent of competition for 75N93020F00003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award